STEADY-STATE TRANSCRIPT LEVELS OF THE TYPE-II HEXOKINASE AND TYPE-1 GLUCOSE-TRANSPORTER IN HUMAN TUMOR-CELL LINES

被引:55
作者
SHINOHARA, Y [1 ]
YAMAMOTO, K [1 ]
KOGURE, K [1 ]
ICHIHARA, J [1 ]
TERADA, H [1 ]
机构
[1] UNIV TOKUSHIMA,FAC PHARMACEUT SCI,TOKUSHIMA 770,JAPAN
关键词
TYPE II HEXOKINASE; TYPE 1 GLUCOSE TRANSPORTER NORTHERN BLOTTING; HUMAN TUMOR CELL LINES;
D O I
10.1016/0304-3835(94)90142-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The steady state transcript levels of two hexokinase isozymes and type 1 glucose transporter in human tumor cell lines were analyzed. In HepG2 cells, both type II hexokinase and type 1 glucose transporter were highly expressed. However, in cell lines A431 and HeLa, in which the expression level of type 1 glucose transporter was lower than that in HepG2 cells, the amount of type II hexokinase transcript was almost negligible.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 24 条
[21]   HUMAN GLUCOKINASE GENE - ISOLATION, STRUCTURAL CHARACTERIZATION, AND IDENTIFICATION OF A MICROSATELLITE REPEAT POLYMORPHISM [J].
TANIZAWA, Y ;
MATSUTANI, A ;
CHIU, KC ;
PERMUTT, MA .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (07) :1070-1081
[22]   HUMAN LIVER GLUCOKINASE GENE - CLONING AND SEQUENCE DETERMINATION OF 2 ALTERNATIVELY SPLICED CDNAS [J].
TANIZAWA, Y ;
KORANYI, LI ;
WELLING, CM ;
PERMUTT, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7294-7297
[23]   COMPLETE AMINO-ACID-SEQUENCE OF THE TYPE-II ISOZYME OF RAT HEXOKINASE, DEDUCED FROM THE CLONED CDNA - COMPARISON WITH A HEXOKINASE FROM NOVIKOFF ASCITES TUMOR [J].
THELEN, AP ;
WILSON, JE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (02) :645-651
[24]   THE NOVEL COMPOUND NO-1886 INCREASES LIPOPROTEIN-LIPASE ACTIVITY WITH RESULTING ELEVATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, AND LONG-TERM ADMINISTRATION INHIBITS ATHEROGENESIS IN THE CORONARY-ARTERIES OF RATS WITH EXPERIMENTAL ATHEROSCLEROSIS [J].
TSUTSUMI, K ;
INOUE, Y ;
SHIMA, A ;
IWASAKI, K ;
KAWAMURA, M ;
MURASE, T .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :411-417